PRMT3 and neoplasm: Since PRMT3 promotes tumor progression through the regulation of arginine methylation, we performed immunoprecipitation-mass spectrometry (IP-MS) analysis using the syngenetic Hepa1-6 cells to identify novel PRMT3 substrates that may be the key downstream effectors regulating the T cell-mediated anti-tumor immunity.